SEBI raises F&O contract size to ₹15 lakhs to curb retail investor frenzy
The new provision mandates that the minimum contract size will be set at ₹15 lakhs, with a maximum cap of ₹20 lakhs. The new contract…
Latest News
Stocks to watch on Oct 3: Suzlon Energy, Aurobindo Pharma, Coal India, NMDC and more
As trading resumes on October 3, investors will want to keep a keen eye on these standout stocks: Suzlon Energy, Aurobindo Pharma, Coal India, NMDC,…
Dabur reports inventory correction impact in second quarter, expects revenue recovery by October
Dabur anticipates a mid-single-digit decline in consolidated revenue for Q2 FY2024-25. However, the international business remains strong, with expectations of double-digit constant currency growth in…
NMDC business update | Navratna firm’s iron ore sales rise 13.8% in September
On a cumulative basis, the company has achieved a total production of 17.47 MT for the financial year up to September 2024, compared to 19.56…
Senco Gold expects gold prices to rise closer to $2,750 by the end of this year
Suvankar Sen, MD & CEO of Senco Gold and Diamonds, observed that while price increases may dampen the volume of gold purchases, demand remains steady…
KRN Heat Exchanger IPO: GMP soars ahead of listing; here’s what to expect
With an upper price band of ₹220, the stock is expected to list at over a 111% premium, potentially delivering multibagger returns to investors who…
SEBI announces new measures to tame speculative retail trading in F&O markets
The proposed changes follow a recent analysis by the Securities and Exchange Board of India (SEBI), which revealed the financial struggles of retail investors in…
Swiggy provides special indemnities to directors of SoftBank, Accel and Prosus, ahead of IPO
Prosus owns 30.95%, while SoftBank and Accel own 7.75% and 6.08%, respectively, of Swiggy. Prosus is eligible to nominate two board members, while SoftBank and…
Aurobindo Pharma secures FDA nod for Cephalexin tablets to treat infections
Shares of the pharma company ended 1.3% lower at ₹1,442.00 on Tuesday.
Suzlon receives advisory warning from NSE and BSE for non-compliance with SEBI regulations
These warnings follow the company’s handling of disclosures related to the resignation of Independent Director, Marc Desaedeleer.